Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer

Journal of Urology

Volumn 157, Issue 1, 1997, Pages 219-222

  Stattin, Pär ^b   Damber, Jan Erik ^b   Karlberg, Lars ^b   Bergh, Anders ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b NONE

Author keywords

antigens; cells; immunohistochemistry; prostatic neoplasms

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; TRANSURETHRAL RESECTION; TUMOR GROWTH;

EID: 0031060408     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65330-8     Document Type: Article

References (18)

1. Lu-Yao, G. L. and Greenberg, E. R.: Changes in prostate cancer incidence and treatment in USA. Lancet, 343: 251, 1994.
2. Vesalainen, S. L. B., Lipponen, P., Talja, M. and Syrjänen, K.: Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate, 26: 80, 1995.
3. Visakorpi, T.: Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. J. Path., 168: 7, 1992.
4. Tinari, N., Natoli, C., Angelucci, D., Tenaglia, R., Fiorentino, B., Di Stefano, P., Amatetti, C., Zezza, A., Nicolai, M. and Iacobelli, S.: DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications. Cancer, 71: 1289, 1993.
5. Harper, M. E., Glynne-Jones, E., Goddard, L., Wilson, D. W., Matenhelia, S. S., Conn, I. G., Peeling, W. B. and Griffiths, K.: Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters. Prostate, 20: 243, 1992.
6. Harper, M. E., Goddard, L., Wilson, D. W., Matanhelia, S. S., Conn, I. G., Peeling, W. B. and Griffiths, K.: Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma. Prostate, 21: 75, 1992.
7. McLoughlin, J., Foster, C. S., Price, P., Williams, G. and Abel, P. D.: Evaluation of Ki-67 monoclonal antibody as prognostic indicator for prostatic carcinoma. Brit. J. Urol., 72: 92, 1993.
8. Gerdes, J.: Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Sem. Cancer Biol., 1: 199, 1990.
9. Scott, R. J., Hall, P. A., Haldane, J. S., van Noorden, S., Price, Y., Lane, D. P. and Wright, N. A.: A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J. Path., 165: 173, 1991.
10. Key, G., Petersen, J. L., Becker, M. H., Duchrow, M., Schlüter, C., Askaa, J. and Gerdes, J.: New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J. Clin. Path., 46: 10, 1993.
11. Harmer, M. H.: TNM Classification of Malignant Tumours, 2 ed. Geneva: Imprimerie G de Buren S. A., 1978.
12. Mostofi, F. K., Sesterhenn, I. A. and Sobin, L. H.: Histological Typing of Prostate Tumours. Geneva: World Health Organization, 1980.
13. Quinn, C. M. and Wright, N. A.: The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J. Path., 160: 93, 1990.
14. Noordzij, M. A., van der Kwast, T. H., van Steenbrugge, G. J., van Weerden, W. M., Oomen, M. A. and Schröder, F. H.: Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues. Prostate, 27: 154, 1995.
15. Vesalainen, S. L., Lipponen, P. K., Talja, M. T., Alhava, E. M. and Syrjänen, K. J.: Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1-2M0 prostatic adenocarcinoma. Int. J. Cancer, 58: 303, 1994.
16. Hall, P. A., Levison, D. A., Woods, A. L., Yu, C. C., Kellock, D. B., Watkins, J. A., Barnes, D. M., Gillet, C. E., Camplejohn, R., Dover, R., Waseem, N. H. and Lane, D. P.: Proliferation cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasm. J. Path., 162: 285, 1990.
17. Bubendorf, L., Sauter, G., Moch, H., Schmid, H. P., Gasser, T. C., Jordan, P. and Mihatsch, M. J.: Ki-67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J. Path., 178: 437, 1996.
18. Bettencourt, M.-C., Bauer, J. J., Sesterhenn, I. A., Mostofi, F. K., McLeod, D. G. and Moul, J. W.: Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol., 156: 1064, 1996.